1 min listen
Moderna vaccine trial pleases investors, EBITDAC backlash, Huawei sanctions
FromFT News Briefing
ratings:
Length:
11 minutes
Released:
May 19, 2020
Format:
Podcast episode
Description
Positive results from the first US Covid-19 trial raised investors’ hopes of an economic rebound, Chinese self-driving car start-ups have been accelerating pilot projects as US rivals sit idle, and bond investors have hit out at the growing trend of companies reporting “earnings before coronavirus”. Plus, the FT’s Kiran Stacey explains what the latest US sanctions against Huawei mean for the Chinese telecoms company’s survival. To get free access to the FT’s Coronavirus Business Update newsletter for 30 days, visit ft.com/newsbriefingcovid or follow this link: https://www.ft.com/newsletter-signup/coronavirus?segmentId=9f398053-342f-c623-b5b3-1506d651696f. See acast.com/privacy for privacy and opt-out information.
Released:
May 19, 2020
Format:
Podcast episode
Titles in the series (100)
Coming soon: A daily rundown of the global business news you need to know for the coming day. FT News Briefing starts Monday, October 15. by FT News Briefing